Ascendis Pharma A (ASND) Long-Term Investments (2018 - 2026)

Ascendis Pharma A (ASND) has 9 years of Long-Term Investments data on file, last reported at $27.6 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments fell 35.95% year-over-year to $27.6 million; the trailing twelve-month figure through Mar 2026 stood at $27.6 million (down 35.95% YoY), and the FY2025 full-year result was $37.9 million, up 157.69% from the prior year.
• Long-Term Investments eased to $27.6 million in Q1 2026, from $37.9 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $43.1 million in Q1 2025 to a low of $6.1 million in Q4 2023.
• A 5-year average of $26.4 million and a median of $26.9 million in 2024 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments slumped 73.85% in 2023 and jumped 161.0% in 2025, its largest moves.
• Tracing ASND's Long-Term Investments over 5 years: stood at $23.4 million in 2022, then tumbled by 73.85% to $6.1 million in 2023, then soared by 137.11% to $14.5 million in 2024, then jumped by 161.0% to $37.9 million in 2025, then slipped by 27.15% to $27.6 million in 2026.
• Business Quant data shows ASND's Long-Term Investments at $27.6 million in Q1 2026, $37.9 million in Q4 2025, and $33.1 million in Q3 2025.